Completed PHASE2 INTERVENTIONAL 1-arm NCT00399490

Open-label Extension Study Of RN624

OPEN-LABEL, MULTIPLE-DOSE STUDY OF THE SAFETY AND EFFICACY OF RN624 IN ADULTS WITH PAIN DUE TO OSTEOARTHRITIS OF THE KNEE.

Sponsor: Pfizer

Conditions Arthritis OA Knee Pain Osteoarthritis

Interventions RN624 (PF-04383119)

Updated 8 times since 2017 Last updated: Jan 11, 2021 Started: Sep 15, 2006 Primary completion: Feb 11, 2008 Completion: Feb 11, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Arthritis and OA Knee Pain, this trial is completed. The trial is conducted by Pfizer and has accumulated 8 data snapshots since 2006. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Dec 2021 — Jul 2024 [monthly]

Completed PHASE2
Mar 2021 — Dec 2021 [monthly]

Completed PHASE2
Jan 2021 — Mar 2021 [monthly]

Completed PHASE2

▶ Show 3 earlier versions

Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Feb 2017 — Jun 2018 [monthly]

Completed PHASE2
Jan 2017 — Feb 2017 [monthly]

Completed PHASE2

First recorded

Sep 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Pfizer

Data source: Pfizer

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Albuquerque, United States , Anaheim, United States , Austin, United States , Birmingham, United States , Boise, United States , Charlottesville, United States , Daytona Beach, United States , Duncansville, United States , Greensboro, United States , Honolulu, United States and 17 more locations